APA

Kang E. M., Hsieh M. M., Metzger M., Krouse A., Donahue R. E., Sadelain M. & Tisdale J. F. (20060323). Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model. : Experimental hematology.

Chicago

Kang Elizabeth M, Hsieh Matthew M, Metzger Mark, Krouse Allen, Donahue Robert E, Sadelain Michel and Tisdale John F. 20060323. Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model. : Experimental hematology.

Harvard

Kang E. M., Hsieh M. M., Metzger M., Krouse A., Donahue R. E., Sadelain M. and Tisdale J. F. (20060323). Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model. : Experimental hematology.

MLA

Kang Elizabeth M, Hsieh Matthew M, Metzger Mark, Krouse Allen, Donahue Robert E, Sadelain Michel and Tisdale John F. Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model. : Experimental hematology. 20060323.